Long-term COVID-19 symptoms in a large unselected population. Preprint
GHDx Entry last modified on: Apr 10, 2023
COVID-19
Dataset Records for COVID-19
Displaying 1251 - 1300 of 1643
Universal Screening for SARS-CoV-2 in Women Admitted for Delivery
GHDx Entry last modified on: Jan 31, 2024
Risk of COVID-19 in health-care workers in Denmark: an observational cohort study
GHDx Entry last modified on: Mar 14, 2022
New Zealand Monthly Notifiable Disease Surveillance Report, January 2021
Epi surveillance:
Subnationally representative
A longitudinal seroprevalence study in a large cohort of working adults reveals that neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independent of the severity of symptoms. Preprint
GHDx Entry last modified on: Jun 18, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Fatality Rate Among Elderly Danes: A Cross-sectional Study on Retired Blood Donors
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 Antibodies in Adults and Healthcare Workers in Southern Italy
GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 seroprevalence and detection fraction in Utah urban populations from a probability-based sample. Preprint.
GHDx Entry last modified on: Mar 14, 2022
High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Juba, South Sudan: a population-based study
GHDx Entry last modified on: Mar 14, 2022
Charting Elimination in the Pandemic: A SARS-CoV-2 Serosurvey of Blood Donors in New Zealand. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 IgG in asymptomatic and pauci-symptomatic people over a 5 month survey in Argentina
GHDx Entry last modified on: Mar 14, 2022
High prevalence of anti-SARS-CoV-2 antibodies after the first wave of COVID-19 in Kinshasa, Democratic Republic of the Congo: results of a cross-sectional household-based survey
GHDx Entry last modified on: Jan 18, 2024
A three-phase population based sero-epidemiological study: Assessing the trend in prevalence of SARS-CoV-2 during COVID-19 pandemic in Jordan
GHDx Entry last modified on: May 12, 2022
Sentinel seroprevalence of SARS-CoV-2 in the Gauteng province, South Africa August to October 2020. Preprint
GHDx Entry last modified on: May 12, 2022
Dyspnoea, lung function and CT findings 3months after hospital admission for COVID-19
GHDx Entry last modified on: Apr 10, 2023
Differences in seroprevalence between epicenter and non-epicenter areas of the COVID-19 outbreak in South Korea
GHDx Entry last modified on: Mar 14, 2022
Onset, duration and unresolved symptoms, including smell and taste changes, in mild COVID-19 infection: a cohort study in Israeli patients
GHDx Entry last modified on: Apr 10, 2023
Seroprevalence of SARS-CoV-2 infection in a municipality in southern Brazil
GHDx Entry last modified on: Jan 31, 2024
Estimation of real-infection and immunity against SARS-CoV-2 in Indian populations. Preprint
GHDx Entry last modified on: Apr 8, 2022
SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital
GHDx Entry last modified on: Mar 14, 2022
Development Assistance for Health on COVID-19 2020
GHDx Entry last modified on: Oct 20, 2022
Universal COVID-19 screening of 4040 health care workers in a resource-limited setting: an Egyptian pilot model in a university with 12 public hospitals and medical centers
GHDx Entry last modified on: Mar 14, 2022
Comparison of Estimated SARS-CoV-2 Seroprevalence through Commercial Laboratory Residual Sera Testing and a Community Survey
GHDx Entry last modified on: Jan 31, 2024
Citywide serosurveillance of the initial SARS-CoV-2 outbreak in San Francisco. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021
GHDx Entry last modified on: May 12, 2022
Finland COVID-19 Cases in the Infectious Disease Registry 2020-2022
COVID-19 Cases in the Infectious Disease Registry
Disease registry:
Epi surveillance
Impact of Recommended Maternal Vaccination Programs on the Clinical Presentation of SARS-CoV-2 Infection: A Prospective Observational Study
GHDx Entry last modified on: Apr 10, 2023
Management of pregnant women with COVID-19: A tertiary pandemic center experience on 1416 cases
GHDx Entry last modified on: Apr 10, 2023
Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study
GHDx Entry last modified on: Jan 31, 2024
Spanish registry of Covid-19 screening in asymptomatic pregnants.
GHDx Entry last modified on: Apr 10, 2023
COVID-19 vaccine equity and booster doses
GHDx Entry last modified on: Dec 12, 2023
Long COVID in children and adolescents: COVID-19 follow-up results in third-level pediatric hospital
GHDx Entry last modified on: Mar 22, 2024
Serological Biomarkers at Hospital Admission Are Not Related to Long-Term Post-COVID Fatigue and Dyspnea in COVID-19 Survivors
GHDx Entry last modified on: Mar 22, 2024
Anti-nucleocapsid antibody levels and pulmonary comorbid conditions are linked to post-COVID-19 syndrome
GHDx Entry last modified on: Mar 22, 2024
Post-COVID-19 syndrome and humoral response association after 1year in vaccinated and unvaccinated patients
GHDx Entry last modified on: Mar 22, 2024
Novel clinical and immunological features associated with persistent post-acute sequelae of COVID-19 after six months of follow-up: a pilot study
GHDx Entry last modified on: Mar 22, 2024
Symptom cluster analysis of long COVID-19 in patients discharged from the Temporary COVID-19 Hospital in Mexico City
GHDx Entry last modified on: Mar 22, 2024
Sri Lanka Epidemiology Unit Coronavirus Disease 2019 (COVID-19) Situation Report 2020-2022
Coronavirus disease 2019 (COVID-19) - Situation Report
Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020
GHDx Entry last modified on: Mar 14, 2022
Remarkable variability in SARS-CoV-2 antibodies across Brazilian regions: nationwide serological household survey in 27 states. Preprint
Scientific literature:
Household
Seroprevalence of COVID-19 in Niger State. Preprint
GHDx Entry last modified on: Mar 4, 2024
Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China
GHDx Entry last modified on: Jan 31, 2024
Clinical predictors and timing of cessation of viral RNA shedding in patients with COVID-19
GHDx Entry last modified on: Mar 14, 2022
Clinical and epidemiological characteristics of pediatric SARS-CoV-2 infections in China: A multicenter case series
GHDx Entry last modified on: Mar 14, 2022
Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection
GHDx Entry last modified on: Mar 14, 2022
Pregnant vs nonpregnant severe acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 hospital admissions: the first 4 weeks in New York
GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study
GHDx Entry last modified on: Feb 16, 2023
Russia Natural Movement of the Population 2020
Естественное Движение Населения В Разрезе Субъектов Российской Федерации За Январь-декабрь 2020 Года
Vital registration:
Subnationally representative
Rwanda COVID-19 Rapid Gender Assessment Survey 2020
Survey:
Cross-sectional - Individual - Interview
Subscribe